How much is good enough? Insights from myocardial infarction incidence during COVID-19 pandemic
Artur Fedorowski1, David Erlinge1
1Department of Cardiology, Skåne University Hospital, Lund - Malmö, Sweden; Department of Clinical Sciences, Lund University, Lund - Malmö, Sweden.
No abstract available in PubMed .
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Myocarditis III: Medical Management
Myocarditis I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease IV: Preventive Measures
